Chance Pharmaceuticals
PrivateLast Round
IPO
Oct 8, 2025
Est. Valuation
$779.1M
Total Funding Raised
$257.86M
Company Overview
Chance Pharmaceuticals is a clinical-stage biotechnology company that specializes in the discovery, development, and commercialization of innovative dry powder inhalation (DPI) therapies for respiratory, central nervous system, and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chance Pharmaceuticals Comparables
Compare Chance Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhejiang Xina Pharmaceutical Co., Ltd. | 78% | |
| Suzhou Inhal Pharma Co., Ltd. | 77% | |
| Transpire Bio Inc. | 77% | |
Chance Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 8, 2025 | ||||
| VC Round | Mar 17, 2025 | ||||
| Series C Extension | Jan 4, 2022 | ||||
| Series C | Oct 11, 2021 | ||||
| Series F | Jul 2, 2020 | ||||
Series E | Jan 2, 2020 |
Chance Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series F |
| Longmen Capital | Series D |
| Oriza Holdings | Series E |
| 招银国际金融有限公司 | IPO |
| SDIC Innovation Investment Management | Series D |
| China Merchants Securities | Series C |
| Lapam Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 66% MoM.
- Jul 2, 2020
$52M round led by Zhongjin Qichen and BioTrack Capital.
Chance Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Chance Pharmaceuticals's valuation, stock price, and market status.